par Patris, Stéphanie ;Vandeput, Marie ;Kenfack, Gersonie, momo;Mertens, Dominique ;Dejaegher, Bieke ;Kauffmann, Jean-Michel
Référence Biosensors & bioelectronics, 77, page (457-463)
Publication Publié, 2015-09
Article révisé par les pairs
Résumé : An immunoassay for the determination of anti-tetani antibodies has been developed using a screen printed electrode (SPE) as solid support for toxoid (antigen) immobilization. The assay was performed in guinea pig serum. The immunoreaction and the subsequent amperometric detection occurred directly onto the SPE surface. The assay consisted of spiking the anti-tetani sample directly onto the toxoid modified SPE, and then a second antibody, i.e. a HRP-labeled anti-immunoglobulin G, was deposited onto the biosensor. Subsequent amperometric detection was realized by spiking 10µL of a hydroquinone (HQ) solution into 40µL of buffer solution containing hydrogen peroxide. An experimental design approach was implemented for the optimization of the immunoassay. The variables of interest, such as bovine serum albumin (BSA) concentration, incubation times and labeled antibody dilution, were optimized with the aid of the response surface methodology using a circumscribed central composite design (CCCD). It was observed that two factors exhibited the greatest impact on the response, i.e. the anti-tetani incubation time and the dilution factor of the labeled antibody. It was discovered that in order to maximize the response, the dilution factor should be small, while the anti-tetani antibody incubation time should be long. The BSA concentration and the HRP-anti-IgG incubation had very limited influence. Under the optimized conditions, the immunoassay had a limit of detection of 0.011IU/mL and a limit of quantification of 0.012IU/mL. These values were below the protective human antibody limit of 0.06IU/mL.

Documents en relation

DI-fusion